Navigation Links
Agenus Implements Genedata End-to-End Biologics Workflow Platform for Immunotherapy R&D
Date:12/4/2019

Genedata, the leading provider of enterprise software solutions for biopharmaceutical R&D, today announced that Agenus, a clinical-stage immuno-oncology company developing therapies to fight cancer, has chosen Genedata Biologics® as a part of their antibody R&D workflow platform. Agenus will use the platform to support immunotherapy and vaccine pipeline programs across their global organization.

“Genedata Biologics was the clear choice as a backbone system to support the full diversity of our complex and rapidly evolving antibody discovery processes in the US and the UK,” said Dennis Underwood, Ph.D., VP Molecular and Information Systems at Agenus. The platform helps streamline Agenus’s growing pipeline of checkpoint-inhibitor candidates and simultaneously supports screening, engineering, expression, purification, and analytics processes for proteins and antibodies, including bispecifics and other innovative next-generation molecules.

Agenus scientists have set path-breaking records delivering new discoveries to the clinic in the past three years. The Genedata Biologics technology, in conjunction with Agenus’s Intelligent (Re)search (AIR) platform, will further augment Agenus scientists’ ability to capture, process, and interpret all large-molecule R&D data and is an important component of the Agenus collaborative data and information platform. Molecule, sample, assay and analytics data, including developability and manufacturability data, are shared between different project teams and sites. This enables systematic and transparent decision-making when selecting therapeutic candidates to be progressed through the clinical development pipeline.

“We are excited that Agenus, a leading company developing unique immune therapies for patients with cancer, has chosen Genedata Biologics as core infrastructure to support their biotherapeutics discovery processes,” said Othmar Pfannes, Ph.D., CEO of Genedata. “This collaboration also demonstrates that innovative, fast-paced biopharma companies can benefit from an integrated data capture and workflow management system. We look forward to a long and productive partnership helping Agenus increase the efficiency of their biologics discovery and development processes.”

About Genedata
Genedata transforms data into intelligence with innovative software solutions and domain-specific consulting services that automate complex, large-scale experimental processes and enable organizations to maximize the ROI in their R&D, spanning early discovery all the way to the clinic. Founded in 1997, Genedata is headquartered in Switzerland with additional offices in Germany, Japan, Singapore, the UK, and the US.
http://www.genedata.com
LinkedIn | Twitter | YouTube

Contact
Miles Fisher-Pollard
Genedata
Public Relations
Phone: +41 61 511 85 61
pr@genedata.com

Disclaimer
The statements in this press release that relate to future plans, events or performance are forward-looking statements that involve risks and uncertainties, including risks associated with uncertainties related to contract cancellations, developing risks, competitive factors, uncertainties pertaining to customer orders, demand for products and services, development of markets for the Company's products and services. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. The Company undertakes no obligation to release publicly the result of any revisions to these forward-looking statements that may be made to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.

All product and service names mentioned are the trademarks of their respective companies.

Read the full story at https://www.prweb.com/releases/agenus_implements_genedata_end_to_end_biologics_workflow_platform_for_immunotherapy_r_d/prweb16759074.htm.


'/>"/>
Source: PRWeb
Copyright©2019 Vocus, Inc.
All rights reserved


Related biology news :

1. IRSF announces 2013 awards and implements new Translational Program
2. Genedata Announces Aptevo Therapeutics Deploys Genedata Biologics to Streamline Cancer Immunotherapy R&D
3. Deep Learning-Based Genedata Imagence® for Automated High-Content Image Analysis Debuts at SLAS Conference
4. Genedata Licenses its Bioprocess Software Platform to Sartorius Stedim Cellca
5. Octapharma Adopts Genedata Bioprocess to Develop Next-generation Bio-manufacturing Processes
6. PrimBio Research Selects Tute as Whole Exome Analysis Provider, Creating Integrated, End-to-End Solution for Next-Generation Sequencing & Data Analysis
7. DNAnexus and QIAGEN Team Up in Education Webinar: Scaling End-to-End NGS Solutions for Clinical Diagnostics in the Cloud
8. MassBiologics receives orphan drug status from FDA for hepatitis C treatment
9. Next-Generation Biologics: R&D, Industry and Market Forecasts 2015-2025
10. Synthetic Biologics Announces Pricing of Public Offering of Common Stock and Warrants
11. Mosaic Biomedicals se une a Northern Biologics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/24/2020)... ... January 24, 2020 , ... Shoreline Biome , ... strain level, today announced that the company will debut a novel new DNA isolation ... , The new product, Shoreline Biome's Rapid Prep kit, is a fast and easy-to-use ...
(Date:1/23/2020)... (PRWEB) , ... January 23, 2020 , ... ... manufacture lifesaving mature red blood cells from stem cells. The red blood ... blood cells, under strictly controlled conditions, for transfusion therapy and replaces the need ...
(Date:1/22/2020)... ... January 21, 2020 , ... ... the company’s new Business Development Department. The move, which is part of the ... previously serving as the company’s Senior Vice President where he oversaw its Cleanroom ...
Breaking Biology News(10 mins):
(Date:2/3/2020)... CAMBRIDGE, Mass. (PRWEB) , ... February 03, 2020 ... ... with US offices in Cambridge, MA, announce that OmniType, the 11-locus, single tube ... from today. OmniType is a best-in-class product featuring locus-multiplexing and short library preparation, ...
(Date:1/27/2020)... PORTLAND, Ore. (PRWEB) , ... January 27, 2020 ... ... the latest advances in neuroscience and cloud and mobile computing, today announced the ... leaders from across an organization to use the latest neuroscience of leadership and ...
(Date:1/24/2020)... ... January 24, 2020 , ... ... RedySmart™ mass flow meters and controllers ideal for BioPharm OEMS. Sierra ... to antiquated rotameters. These thermal instruments employ high-precision MEMS (Micro-Electro Mechanical Systems) technology ...
(Date:1/22/2020)... ... January 21, 2020 , ... COBO Technologies and ... editing. The partners have agreed to co-develop and market a portfolio of CRISPR ... pre-clinical programs. Over the longer-term, the parties aim to develop a COBO branded ...
Breaking Biology Technology: